Results 71 to 80 of about 6,565 (207)

Insulin pump therapy would be favored by pregnant women with diabetes

Cogent Psychology, 2020
To evaluate retrospectively the satisfaction of continuous subcutaneous insulin infusion (CSII) compared to multiple daily infusions in Japanese women with diabetes mellitus (DM) during pregnancy, we examined 27 women with type 1 (n = 20) or type 2 (n ...
Aya Osaki, Eijiro Yamada, Yasuyo Nakajima, Yuko Kasai, Yoko Shimoda, Akiko Toki, Kazuhiko Horiguchi, Satoshi Yoshino, Maki Inoue, Tsugumichi Saito, Takashi Kameda, Shuichi Okada, Masanobu Yamada   +12 more
doaj   +1 more source

Mean BG profiles of patients under CSII treatment, basal insulin isophane, and standard-of-care over 7 days after transplantation.

, 2018
CSII patients had significantly lower BG compared to the control group for all times of the day except for pre-lunch and compared to the basal insulin group for fasting and post-supper glucose (2-way ANOVA, Bonferroni post-hoc test): (A) fasting ...
Peter X. K. Song (2827454), Johannes J. Kovarik (3930809), Wolfgang Brozek (68740), Johannes M. Werzowa (4922866), Julio Pascual (404967), Chantal Kopecky (3930806), Manfred Hecking (650466), Andreas Thomas (1703893), Marcus D. Säemann (606867), Marlies Antlanger (3615428), Alexander Mohl (4922869), Christopher C. Kaltenecker (3930794), Michael Bergmann (137488), Michael Haidinger (4922872), Klemens Budde (4344541)   +14 more
core   +1 more source

CSII [PDF]

Journal of Diabetes Science and Technology, 2015
Jean-Luc, Ardilouze, Julie, Ménard, Fernand, Gobeil, Maude, Gagnon-Auger, Ghislaine, Houde, Marie-Hélène, Pesant, Rémi, Rabasa-Lhoret, Jean-Patrice, Baillargeon   +7 more
openaire   +2 more sources

Rate of microvascular complications according to insulin delivery: CSII vs MDI.

, 2016
Rate of microvascular complications according to insulin delivery: CSII vs MDI.
Sohaib A. Virk (2601013), Yoon Hi Cho (2601004), Paul Z. Benitez-Aguirre (2601019), Kim C. Donaghue (2601007), Bedowra Zabeen (2601010), Alison Pryke (2601016), Stephen Hing (2601022), Maria E. Craig (291159), Albert K. F. Chan (2601001)   +8 more
core   +1 more source

Systems of continuous subcutaneous insulin infusion to maintain metabolic compensation for type 1 diabetes mellitus among children and adolescents

Сахарный диабет, 2019
BACKGROUND: Insulin pumps (IP) are a widespread treatment for type 1 diabetes mellitus (T1D) in children because of its several advantages over multiple insulin injection regimens (MII).
Elena B. Bashnina, Irina M. Tsargasova, Olga A. Klitsenko   +2 more
doaj   +1 more source

Effect of CSII plus CGM treatment on gastroparesis symptoms, quality of life, and meal tolerance.

, 2018
Effect of CSII plus CGM treatment on gastroparesis symptoms, quality of life, and meal tolerance.
Marina Basina (5100506), Kristen Hairston (5100536), Ronnie Fass (5100500), James Tonascia (665058), Richard W. McCallum (4607659), Tamis Bright (5100527), William J. Snape (4607662), Thomas L. Abell (4607653), Jorge Calles-Escandón (5100521), William L. Hasler (819186), Pankaj J. Pasricha (351642), Frank Hamilton (5100503), Gianrico Farrugia (467593), Linda A. Lee (5100518), Irene Sarosiek (4607656), Karen Earle (5100512), Henry P. Parkman (4607677), Elias S. Siraj (5100539), Andrew T. Kraftson (5100515), Laura A. Miriel (5100542), Angela Subauste (233758), Kjersti Kirkeby (5100530), Ivana A. Vaughn (5100509), Bruce Buckingham (5100533), Kenneth L. Koch (785037), Mark L. Van Natta (564599), Amy E. Rothberg (5100524), William H. Herman (666277), Linda Nguyen (195959)   +28 more
core   +1 more source

Continuous Subcutaneous Insulin Infusion (CSII)

Diabetologia Croatica, 2003
Intensive diabetes management can be achieved in children, adolescents and adults either with the use of continuous subcutaneous insulin infusion or with multiple daily injections. The goals of intensive diabetes management established by the Diabetes Control and Complications Trial are to achieve near normal glycemia, to avoid short-term crises such ...
Prašek, Manja, Metelko, Željko
openaire   +2 more sources

Relationship Between hsCRP, Glycaemic Control and Response to Sotagliflozin in Type 1 Diabetes: A Post Hoc Analysis of the inTandem3 Trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 9695-9700, October 2026.
Luxcia Kugathasan, Michael J. Davies, Manon Girard, Erik Moedt, Marcel H. A. Muskiet, David Z. I. Cherney   +5 more
wiley   +1 more source

MDI versus CSII in Chinese adults with type 1 diabetes in a real-world situation: based on propensity score matching method

Health and Quality of Life Outcomes
Background Compared with multiple daily insulin injections (MDI), continuous subcutaneous insulin infusion (CSII) is significantly more expensive and has not been widely used in Chinese type 1 diabetes mellitus (T1DM) patients.
Jian Yu, Hong Wang, Min Zhu, Jingjing Xu
doaj   +1 more source

Continuous Insulin Therapy to Prevent Post-Transplant Diabetes Mellitus: A Randomized Controlled Trial

Kidney Medicine
Rationale & Objectives: Hyperglycemia is frequently observed early after transplantation and associated with development of post-transplant diabetes mellitus (PTDM).
Amelie Kurnikowski, Johannes Werzowa, Sebastian Hödlmoser, Simon Krenn, Christopher Paschen, Sebastian Mussnig, Andrea Tura, Jürgen Harreiter, Michael Krebs, Peter X.K. Song, Kathrin Eller, Julio Pascual, Klemens Budde, Manfred Hecking, Elisabeth Schwaiger   +14 more
doaj   +1 more source